Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 8.86%14.13B | 3.80%8.69B | 9.05%4.36B | 6.48%18.06B | 1.95%12.98B | 1.44%8.37B | 1.70%4B | 10.65%16.97B | 12.71%12.73B | 17.37%8.25B |
| Operating income | 8.86%14.13B | 3.80%8.69B | 9.05%4.36B | 6.48%18.06B | 1.95%12.98B | 1.44%8.37B | 1.70%4B | 10.65%16.97B | 12.71%12.73B | 17.37%8.25B |
| Cost of sales | -20.85%-9.1B | -12.03%-5.24B | -7.96%-2.46B | -10.72%-10.81B | -6.11%-7.53B | 2.16%-4.68B | -3.14%-2.28B | -4.28%-9.77B | -7.48%-7.09B | -13.47%-4.78B |
| Operating expenses | -20.85%-9.1B | -12.03%-5.24B | -7.96%-2.46B | -10.72%-10.81B | -6.11%-7.53B | 2.16%-4.68B | -3.14%-2.28B | -4.28%-9.77B | -7.48%-7.09B | -13.47%-4.78B |
| Gross profit | -7.70%5.03B | -6.65%3.44B | 10.49%1.9B | 0.74%7.25B | -3.29%5.45B | 6.40%3.69B | -0.14%1.72B | 20.66%7.2B | 20.07%5.64B | 23.22%3.46B |
| Administrative expenses | -19.05%-106.85M | 13.73%-49.73M | 28.76%-16.62M | 12.55%-160.89M | 18.50%-89.75M | 11.74%-57.65M | 13.17%-23.33M | -3.71%-183.98M | -24.32%-110.11M | -11.08%-65.32M |
| Impairment and provision | -92.92%-20.61M | 107.44%2.21M | 67.42%3.65M | 36.47%-19.45M | 85.51%-10.68M | 50.90%-29.66M | 104.17%2.18M | -159.86%-30.62M | -190.56%-73.75M | -1,464.75%-60.42M |
| -Other impairment is provision | -92.92%-20.61M | 107.44%2.21M | 67.42%3.65M | 36.47%-19.45M | 85.51%-10.68M | 50.90%-29.66M | 104.17%2.18M | -159.86%-30.62M | -190.56%-73.75M | -1,464.75%-60.42M |
| Special items of operating profit | -34.17%375.49M | -65.75%130.81M | -45.52%129.31M | 35.92%2.46B | -48.09%570.36M | 934.19%381.93M | 56.66%237.33M | -31.97%1.81B | 53.90%1.1B | -90.51%36.93M |
| Operating profit | -10.83%5.28B | -11.47%3.52B | 4.17%2.02B | 8.38%9.53B | -9.62%5.92B | 17.93%3.98B | 7.87%1.94B | 4.24%8.79B | 23.75%6.55B | 7.57%3.38B |
| Financing cost | 14.85%-1.13B | 17.63%-749.53M | 21.29%-371.81M | 17.23%-1.74B | 10.18%-1.33B | 6.39%-909.96M | 1.21%-472.4M | -11.07%-2.1B | -7.86%-1.48B | -7.41%-972.07M |
| Share of profits of associates | 16.02%907.4M | 14.58%579.68M | 17.03%289.71M | -11.06%939.4M | -7.45%782.11M | -12.36%505.92M | -1.08%247.55M | 40.44%1.06B | 34.96%845.04M | 41.28%577.25M |
| Share of profit from joint venture company | 1,000.77%136.51M | 2,256.39%93.53M | 394.44%67.46M | 22.14%130.74M | -74.53%12.4M | -87.93%3.97M | -29.88%13.64M | 115.08%107.05M | 8.33%48.69M | 67.97%32.88M |
| Special items of earning before tax | 140.91%2.48B | 146.38%1.42B | -1.49%457.15M | ---- | --1.03B | -35.12%574.77M | -22.97%464.08M | ---- | ---- | --885.86M |
| Earning before tax | 19.57%7.68B | 17.05%4.86B | 12.34%2.46B | 12.81%8.86B | 7.55%6.42B | 6.57%4.16B | 0.02%2.19B | 6.94%7.85B | 29.85%5.97B | 46.53%3.9B |
| Tax | -23.46%-1.51B | -15.72%-939.6M | -9.77%-485.33M | -38.39%-1.7B | -26.68%-1.22B | -29.72%-811.95M | -44.47%-442.15M | -18.30%-1.23B | -13.83%-963.97M | -1.91%-625.91M |
| After-tax profit from continuing operations | 18.65%6.17B | 17.37%3.92B | 12.99%1.98B | 8.07%7.16B | 3.86%5.2B | 2.14%3.34B | -7.19%1.75B | 5.07%6.62B | 33.47%5.01B | 59.91%3.27B |
| Earning after tax | 18.65%6.17B | 17.37%3.92B | 12.99%1.98B | 8.07%7.16B | 3.86%5.2B | 2.14%3.34B | -7.19%1.75B | 5.07%6.62B | 33.47%5.01B | 59.91%3.27B |
| Minority profit | 84.70%1.98B | 71.31%1.14B | 39.76%498.41M | 18.32%1.65B | -0.83%1.07B | -7.20%663.8M | -3.83%356.62M | 24.40%1.4B | 33.44%1.08B | 55.17%715.27M |
| Profit attributable to shareholders | 1.51%4.19B | 4.01%2.79B | 6.14%1.48B | 5.32%5.5B | 5.16%4.13B | 4.75%2.68B | -8.02%1.39B | 0.87%5.22B | 33.48%3.93B | 61.29%2.56B |
| Basic earnings per share | 1.51%0.6991 | 4.00%0.4651 | 6.15%0.2468 | -18.73%0.9179 | -23.80%0.6887 | -20.40%0.4472 | -30.12%0.2325 | -0.68%1.1295 | 33.48%0.9038 | 53.83%0.5618 |
| Diluted earnings per share | 3.39%0.6991 | 5.61%0.4651 | 8.20%0.2468 | -14.07%0.905 | -20.53%0.6762 | -18.38%0.4404 | -27.40%0.2281 | -2.78%1.0532 | 36.47%0.8509 | 47.75%0.5396 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
| Auditor | -- | -- | -- | Ernst & Young, Yung Shing (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.